Evaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Diabetic Foot Ulcers
NCT: NCT07840378 · NOT_YET_RECRUITING
NCT IDNCT07840378
StatusNOT_YET_RECRUITING
Start Date2026-09
Completion2027-06
SponsorTiger Biosciences, LLC. (INDUSTRY)
First posted
Last updated
Brief Summary
To prospectively evaluate the safety and efficacy of an Autologous Platelet-Rich Fibrin Plasma system when applied in conjunction with Standard of Care for management of chronic Diabetic Foot Ulcers.
Frequently Asked Questions
What is Evaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Diabetic Foot Ulcers?
Evaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Diabetic Foot Ulcers is a clinical trial registered under NCT07840378. Current status: NOT_YET_RECRUITING.
What is the status of NCT07840378?
The current status of NCT07840378 (Evaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Diabetic Foot Ulcers) is: NOT_YET_RECRUITING.
When did Evaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Diabetic Foot Ulcers start?
Evaluating Autologous Platelet-Rich Fibrin Plasma for Chronic Diabetic Foot Ulcers started on 2026-09.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.